No, Mobia Medical (developer of the Vivistim neurostimulation platform, historically known as MicroTransponder) has not gone public via an IPO. The medical technology enterprise has historically funded its clinical trials and commercial scaling phases through private venture capital financing rounds and strategic institutional investments rather than public stock market listings.